QRT‐PCR analysis showed significantly lower expression of the genes: MAPK3 encoding ERK1 and MAPK1 encoding ERK2, p38, β‐catenin and E‐cadherin in prostate adenocarcinoma compared to BPH tissues (Figure 6). This evidence concerns the gene MAPK1 and prostate adenocarcinoma.